Screener
Vor Biopharma VOR Issuance Of Pre Funded Warrants In Connection With Acquisition Of In Process Research And Development
Issuance Of Pre Funded Warrants In Connection With Acquisition Of In Process Research And Development at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept vor:IssuanceOfPreFundedWarrantsInConnectionWithAcquisitionOfInProcessResearchAndDevelopment.
The source filing: Vor Biopharma’s 10-K, filed March 30, 2026. Open the filing →
- Filed
- Mar 30, 2026, 8:03 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-130451
FAQ
- What is Vor Biopharma's issuance of pre funded warrants in connection with acquisition of in process research and development?
- Vor Biopharma (VOR) reported issuance of pre funded warrants in connection with acquisition of in process research and development of $44.34M in Q4 2025.
- What does issuance of pre funded warrants in connection with acquisition of in process research and development mean?
- This represents the non-cash consideration provided in the form of pre-funded warrants to acquire intellectual property or research and development assets. It highlights the company's strategy for inorganic growth and pipeline expansion.
Ask your AI about Vor Biopharma's issuance of pre funded warrants in connection with acquisition of in process research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude